AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

EMTRICITABINE & TENOFOVIR ALAFENAMIDE

25 registrations across 6 African markets— 23 active

Markets with EMTRICITABINE & TENOFOVIR ALAFENAMIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DOBATAF-EM TABLETS (Each film-coated tablet contains Emtricitabine/Tenofovir Alafenamide /200mg/25mg)🇬🇭GhanaactiveApr 2031
DOBATAF-EM TABLETS (Each film-coated tablet contains Emtricitabine/Tenofovir Alafenamide /200mg/25mg)🇬🇭GhanaactiveApr 2031
DOBATAF-3 TABLETS Each contains Emtricitabine/Tenofovir Alafenamide 200mg/25mg)🇬🇭GhanaactiveJan 2031
DOBATAF-3 TABLETS Each contains Emtricitabine/Tenofovir Alafenamide 200mg/25mg)🇬🇭GhanaactiveJan 2031
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE​ ​TABLETS🇬🇭GhanaactiveDec 2029
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE​ ​TABLETS🇬🇭GhanaactiveDec 2029
EMTRICITABINE; TENOFOVIR ALAFENAMIDE
TABLET, COATED; ORAL
🇿🇼ZimbabweCIPLA LTDactiveOct 2029
EMTRICITABINE; TENOFOVIR ALAFENAMIDE
TABLET, COATED; ORAL
🇿🇼ZimbabweMYLAN LABORATORIES LIMITEDactiveAug 2029
EMTRICITABINE ; TENOFOVIR ALAFENAMIDE
TABLET, COATED; ORAL
🇿🇼ZimbabweLAURUS LABS LIMITEDactiveOct 2028
EMTRICITABINE; TENOFOVIR ALAFENAMIDE
TABLET, COATED; ORAL
🇿🇼ZimbabweHETERO LABS LTDactiveFeb 2028
DESCOVY
TABLET, COATED; ORAL
🇿🇼ZimbabweGILEAD SCIENCES INCactiveDec 2027
EMTRICITABINE_&TENOFOVIR_ALAFENAMIDE 200/25MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
EMTRICITABINE_TENOFOVIR-ALAFENAMIDE 200MG/25MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2024
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
Emtricitabine/Tenofovir alafenamide Tablet 200 mg/25 mg
Tablet
🌍WWMacleods Pharmaceuticals Ltdactive
Emtricitabine/Tenofovir alafenamide Tablet, Film-coated 200mg/25mg
Tablet, Film-coated
🌍WWAurobindo Pharma Ltdactive
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaGILEAD SCIENCES INCactive
DESCOVY
comprimé pelliculé / 10 mg / 200 mg
🇸🇳SenegalGILEAD SCIENCESactive
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaGILEAD SCIENCES INCactive
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaGILEAD SCIENCES INCactive
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
EMTRICITABINE + TENOFOVIR ALAFENAMIDE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaGILEAD SCIENCES INCactive
Emtricitabine/Tenofovir alafenamide Tablet 200mg/25mg
Tablet
🌍WWMylan Laboratories Ltd.active

EMTRICITABINE & TENOFOVIR ALAFENAMIDE in Africa — Regulatory Overview

EMTRICITABINE & TENOFOVIR ALAFENAMIDE is registered across 6 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Ghana, Zimbabwe, WW and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 25 registrations, 23 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.